# FDA Inspection 977281 - Wake Forest Institute for Regenerative Medicine - July 20, 2016

Source: https://www.keypedia.com/records/fda_inspections/wake-forest-institute-for-regenerative-medicine/3cf273ad-0a1d-4341-b504-37a5f09ea0ea
Source feed: FDA_Inspections

> FDA Inspection 977281 for Wake Forest Institute for Regenerative Medicine on July 20, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 977281
- Company Name: Wake Forest Institute for Regenerative Medicine
- Inspection Date: 2016-07-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1057473 - 2018-06-21](https://www.keypedia.com/records/fda_inspections/wake-forest-institute-for-regenerative-medicine/343167c5-0811-4a49-8c25-99e2de5a7b8a)

Company: https://www.keypedia.com/companies/wake-forest-institute-for-regenerative-medicine/50ee2c80-3ec8-4fc1-940a-e4c20611fa28

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d